Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Infants“
Suchtreffer
Begriffe & Kennungen
Bexsero · 4.8 · 6 Infants and children (up to 10 years of age)
Eintrag öffnenBexsero · 4.8 · In clinical studies in infants vaccinated at 2, 4 and 6 months of age, fever (≥ 38 °C) was reported by 69% to
Eintrag öffnenBexsero · 4.8 · In infants and children (less than 2 years of age) the most common local and systemic adverse reactions observ
Eintrag öffnenBeyfortus · 4.8 · 5 second RSV season was consistent with the safety profile of nirsevimab in term and preterm infants GA ≥29 we
Eintrag öffnenBeyfortus · 4.8 · Infants at higher risk for severe RSV disease in their first season
Eintrag öffnenBeyfortus · 4.8 · Safety was evaluated in MEDLEY in 918 infants at higher risk for severe RSV disease, including 196 extremely p
Eintrag öffnenBeyfortus · 4.8 · Table 1 presents the adverse reactions reported in 2 966 term and preterm infants (GA ≥29 weeks) who received
Eintrag öffnenBeyfortus · 4.8 · Term and Preterm Infants entering their first RSV season
Eintrag öffnenBuccolam · 4.5 · The effect of CYP3A4 inhibitors may be larger in infants since part of the oromucosal dose is probably swallow
Eintrag öffnenComirnaty · 4.8 · Infants 6 months to 23 months of age - after at least 3 doses In 3 groups from Study 6 (Phase 1), 95 participa
Eintrag öffnenComirnaty · 4.8 · Infants 6 months to 23 months of age - after at least 3 doses In 3 groups from Study 6 (Phase 1), 95 participa
Eintrag öffnenComirnaty · 4.8 · Infants 6 months to 23 months of age - after at least 3 doses In 3 groups from Study 6 (Phase 1), 95 participa
Eintrag öffnenComirnaty · 4.8 · Infants 6 months to 23 months of age - after at least 3 doses In 3 groups from Study 6 (Phase 1), 95 participa
Eintrag öffnenComirnaty · 4.8 · Infants 6 months to 23 months of age - after at least 3 doses In 3 groups from Study 6 (Phase 1), 95 participa
Eintrag öffnenComirnaty · 4.8 · Infants born to pregnant participants – after 2 doses of Comirnaty Study C4591015 (Study 9), a Phase 2/3, plac
Eintrag öffnenComirnaty · 4.8 · Infants born to pregnant participants – after 2 doses of Comirnaty Study C4591015 (Study 9), a Phase 2/3, plac
Eintrag öffnenComirnaty · 4.8 · Infants born to pregnant participants – after 2 doses of Comirnaty Study C4591015 (Study 9), a Phase 2/3, plac
Eintrag öffnenComirnaty · 4.8 · Infants born to pregnant participants – after 2 doses of Comirnaty Study C4591015 (Study 9), a Phase 2/3, plac
Eintrag öffnenComirnaty · 4.8 · Infants born to pregnant participants – after 2 doses of Comirnaty Study C4591015 (Study 9), a Phase 2/3, plac
Eintrag öffnenComirnaty · 4.8 · Initially approved Comirnaty vaccine Infants 6 to 23 months of age – after 3 doses of the 3 mcg primary series
Eintrag öffnen